SECOND AMENDMENT TO THE RESEARCH AGREEMENT BETWEEN LEXEO THERAPEUTICS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ON BEHALF OF ITS SAN DIEGO CAMPUS
Exhibit 10.29
[ *** ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
SECOND AMENDMENT TO THE RESEARCH AGREEMENT BETWEEN LEXEO THERAPEUTICS, INC.
AND
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ON BEHALF OF ITS SAN DIEGO CAMPUS
This Second Amendment (“Amendment”) by and between LEXEO Therapeutics, Inc. located at ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ (“Sponsor”) and The Regents of the University of California on behalf of its San Diego Campus, located at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ #▇▇▇▇, ▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ (“Institution”) is made and effective as of the last date of signature (“Effective Date”).
WHEREAS, Sponsor and Institution entered into the Research Agreement, effective on December 3, 2021 (“Agreement”), to conduct a research project entitled [***] (“Project”);
WHEREAS, Sponsor and Institution subsequently entered into a First Amendment to the Agreement, effective on April 5, 2023 (“First Amendment”);
WHEREAS, Sponsor and Institution mutually desire to further amend the First Amendment as set forth below;
NOW THEREFORE, in consideration of the premises and mutual covenants herein, the parties agree as follows:
1
IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their duly authorized representatives as of the Effective Date.
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, on behalf of its San Diego Campus |
|
|||
|
|
|
|
|
By: |
/s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ |
|
By: |
/s/ R. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ |
Print Name: |
▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ |
|
Print Name: |
▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ |
Title: |
Principal Contract and Grant Analyst |
|
Title: |
Chief Executive Officer |
2
Exhibit A: Revised Scope of Work and Budget
[***]
3